methyl methanesulfonate has been researched along with Cancer of Esophagus in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wang, Y | 1 |
Zang, W | 1 |
Du, Y | 1 |
Chen, X | 1 |
Zhao, G | 1 |
Barnas, C | 1 |
Martel-Planche, G | 1 |
Furukawa, Y | 1 |
Hollstein, M | 1 |
Montesano, R | 1 |
Hainaut, P | 1 |
Sheikh, MS | 1 |
Huang, Y | 1 |
Fernandez-Salas, EA | 1 |
El-Deiry, WS | 1 |
Friess, H | 1 |
Amundson, S | 1 |
Yin, J | 1 |
Meltzer, SJ | 1 |
Holbrook, NJ | 1 |
Fornace, AJ | 1 |
3 other studies available for methyl methanesulfonate and Cancer of Esophagus
Article | Year |
---|---|
The K167I variant of DNA polymerase β that is found in Esophageal Carcinoma patients impairs polymerase activity and BER.
Topics: Analysis of Variance; Antineoplastic Agents, Alkylating; Apoptosis; Cell Line, Tumor; Cell Survival; | 2015 |
Inactivation of the p53 protein in cell lines derived from human esophageal cancers.
Topics: Base Sequence; Blotting, Western; DNA; DNA Damage; Esophageal Neoplasms; Humans; Hydrogen Peroxide; | 1997 |
The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma; | 1999 |